Viavi insider sell‑off: 25,000 shares at $29.23, 1 % of holdings, amid a 13.6 % weekly rise and product launch. No distress signal, just profit‑taking.
Insider sale by Itron’s senior executive shows routine, tax‑driven trading; a small impact on shares while the company strengthens its balance sheet with a $700 million convertible debt offering, supporting long‑term growth.
Insider trading at IonQ shows executive buying outweighs a small sale, highlighting confidence in a new defense contract and quantum‑tech growth prospects.
Belden insider sales reveal routine tax‑planning, not a change in confidence. Executive Tate Leah’s 425‑share February sale keeps her long‑term stake intact, supporting a bullish view of the company’s growth trajectory.
IonQ insider sales show confidence, not panic: Director sells 616 shares for diversification while executives buy, signaling bullish outlook on defense contract and quantum‑hardware growth.